Bridgebio Pharma, Inc. (BBIO) — DEF 14A Filings
All DEF 14A filings from Bridgebio Pharma, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
BridgeBio Pharma Files 2025 Proxy Statement
— Apr 30, 2025 Risk: low
BridgeBio Pharma, Inc. filed its definitive proxy statement (DEF 14A) on April 30, 2025, for its annual meeting on June 20, 2025. The filing outlines the compan -
BridgeBio Pharma, Inc. Announces 2024 Annual Meeting of Stockholders on June 21, 2024
— Apr 25, 2024 Risk: low
BridgeBio Pharma, Inc. (BBIO) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. BridgeBio Pharma, Inc. will hold its 2024 Annual Meeting of Stoc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX